The world's first brain-computer interface innovative product has obtained medical insurance coding.

On March 13, 2026, the world's first invasive brain-machine interface medical device was officially approved for listing. On March 15, the National Medical Insurance Bureau proactively coordinated and provided advanced services for this product to complete the medical insurance coding, successfully connecting the key link from approval to clinical application of innovative products, marking the brain-machine interface industry officially transitioning from "planning blueprint" to "fast track to implementation". The approved "Implantable Brain-Machine Interface Hand Movement Compensation System" is mainly targeted towards high-level paraplegic patients caused by spinal cord injury. These patients lose hand function completely due to damage to the spinal cord connecting the brain and limbs, leading to severe lifelong paralysis and great difficulty in rehabilitation, and placing a heavy burden on family care. Currently, there are over 3.7 million spinal cord injury patients in China, increasing at a rate of approximately 90,000 people per year. This innovative product brings "light of hope" to these patients. By implanting a coin-sized minimally invasive device in the patient's skull, the system can real-time collect and decode brain electrical signals, allowing patients to control an external pneumatic glove with their "thoughts" to independently complete daily actions such as gripping, grabbing objects, and drinking water. Just one month after surgery, patients can operate independently at home. This breakthrough provides a new "Chinese solution" for the world-class medical challenge of spinal cord injury repair.